Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Treatment.com International ( (TSE:TRUE) ).
Treatment.com AI Inc. has announced a new non-dilutive M&A credit facility of up to $1.5 million to fund expenses related to strategic acquisitions like Rocket Doctor. This facility is intended to support the company’s growth through revenue-boosting acquisitions, enhancing its market position in the healthcare industry by enabling the company to expand its operations without issuing new securities.
More about Treatment.com International
Treatment.com AI Inc. is a healthcare company that leverages artificial intelligence and best clinical practices to address inefficiencies in the healthcare sector. The company has developed the Global Library of Medicine (GLM), a comprehensive AI engine providing clinical information and support to healthcare professionals, helping to reduce administrative burdens and promote health equity.
YTD Price Performance: 30.0%
Average Trading Volume: 7,824
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.23M
Find detailed analytics on TRUE stock on TipRanks’ Stock Analysis page.
